FDA approves selpercatinib for locally advanced or metastatic RET fusion-positive non-small cell lung cancer

[FDA]

FDA approves selpercatinib for locally advanced or metastatic RET fusion-positive non-small cell lung cancer


Baca selengkapnya di : http://www.fda.gov...